Clinical Focus
Business Focus
Spotlight
Subscribe
CE/CME
- CDC News
- Adult Immunization
- Hepatology
- Rare Disorders
- Pediatric Immunization
- Weight Management
- Screening
- Psychiatry
- Allergy
- Women's Health
- Cardiology
- Pediatrics
- Kidney Disease
- Dermatology
- Endocrinology
- Pain Management
- Gastroenterology
- Geriatrics
- Infectious Disease
- Orthopedics
- Obesity Medicine
- Rheumatology
- Technology
- Oncology
- Nephrology
- Neurology
- Pulmonology
NIH COVID-19 Treatment Guidelines Update: Colchicine, mAbs, Convalescent Plasma
The April 21st updates include guidance on use of colchicine, when to use combination anti-SARS-CoV-2 monoclonal antibodies, COVID-19 reinfection, and "long COVID."
The National Institutes of Health Coronavirus Disease 2019 (COVID-19) Treatment Guidelines are updated monthly and the most recent additions and revisions were released on April 21, 2021.
The following slides offer an at-a-glance review of the 3 new sections added and the 7 key updates to existing sections. Links to each section are provided in slide captions for more extensive reading.
Related Videos
Related Content
